1. Home
  2. AGM vs MIRM Comparison

AGM vs MIRM Comparison

Compare AGM & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federal Agricultural Mortgage Corporation

AGM

Federal Agricultural Mortgage Corporation

HOLD

Current Price

$177.59

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$79.25

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGM
MIRM
Founded
1987
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
3.4B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
AGM
MIRM
Price
$177.59
$79.25
Analyst Decision
Buy
Strong Buy
Analyst Count
1
11
Target Price
$219.00
$92.45
AVG Volume (30 Days)
77.0K
818.0K
Earning Date
11-03-2025
11-04-2025
Dividend Yield
3.37%
N/A
EPS Growth
12.85
N/A
EPS
17.55
N/A
Revenue
$377,946,000.00
$471,794,000.00
Revenue This Year
$14.80
$53.78
Revenue Next Year
$9.98
$19.91
P/E Ratio
$10.15
N/A
Revenue Growth
8.81
53.66
52 Week Low
$155.00
$36.88
52 Week High
$212.24
$82.58

Technical Indicators

Market Signals
Indicator
AGM
MIRM
Relative Strength Index (RSI) 54.99 62.89
Support Level $175.04 $63.23
Resistance Level $179.98 $82.58
Average True Range (ATR) 4.22 3.74
MACD -0.60 1.62
Stochastic Oscillator 30.80 81.03

Price Performance

Historical Comparison
AGM
MIRM

About AGM Federal Agricultural Mortgage Corporation

Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven segments: Farm & Ranch, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: